2025 Volume 51 - Canada Communicable Disease Report (CCDR)

Submit a manuscript
About CCDR
Browse
ISSN: 1481-8531
2025 Volume 51
CCDR Volume 51-2/3, February/March 2025: Health Economics in Public Health
- Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison
- Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: a cost-utility analysis
- Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations
- Public Health Risks Associated with Dog Importation
- Summary of the mpox outbreak in Canada, April 28−December 31, 2022
- Differences in sensationalism in international news media reporting of COVID-19: An exploratory analysis using the Global Public Health Intelligence Network (GPHIN) system
- Infectious syphilis and congenital syphilis in Canada, 2023
CCDR Volume 51-1, January 2025: Personal Protective Measures
- Summary of the National Advisory Committee on Immunization (NACI) Statement—Updated guidance on Imvamune in the context of a routine immunization program
- Is there sufficient evidence to inform personal protective equipment choices for healthcare workers caring for patients with viral hemorrhagic fevers?
- Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023
- Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infection
- The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018–2021
- Using behavioural science to improve antibiotic stewardship in Canadian long-term care homes: Protocol for a multi-center cluster randomized quality improvement study
Page details
- Date modified: